Researchers at UCL have developed an innovative AI tool called MindGlide, designed to transform the way MS treatments are ...

Explore the INNOCN 49Q1S OLED Ultra Wide, a 49-inch curved monitor with HDR, KVM switch, and ergonomic design for gaming, ...

Every year, cybersecurity watchers tally up the largest data breaches, typically ranked by the billions of records exposed or ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosisResults from the HERCULES phase 3 ...

The New England Journal of Medicine (NEJM) published positive results from the HERCULES phase 3 study demonstrating that tolebrutinib delayed disability progression in people with non-relapsing ...

Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...

Sensitive information exposed in the incident includes health insurance information, Social Security numbers, and financial ...

Sanofi announces tolebrutinib phase 3 study data published in NEJM shows benefit on disability progression in multiple sclerosis: Paris Thursday, April 10, 2025, 10:00 Hrs [IST] T ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed.

Nuclear and clean energy advocates warned that cuts Elon Musk’s Department of Government Efficiency is considering for the ...

Minneapolis officials have created a new emergency incident dashboard that they say will allow people to monitor categorized ...